{"abstract":"The National Eye Institute, an institute of the National Institutes of Health, United States Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patent applications listed in the SUPPLEMENTARY INFORMATION section of this notice to Perpetual Biosciences, Inc., a company located in New York, NY.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/04/01/2026-06283.html","cfr_references":[],"citation":"91 FR 16205","comment_url":null,"comments_close_on":"2026-04-16","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center, representing the National Eye Institute, on or before April 16, 2026 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2026-06283","effective_on":null,"end_page":16206,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/04/01/2026-06283.xml","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06283/prospective-grant-of-an-exclusive-patent-license-pigment-epithelium-derived-factor-pedf-peptides-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-06283?publication_date=2026-04-01","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-04-01/2026-06283/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":194,"last_updated":"2026-09-20 22:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-01/pdf/2026-06283.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06283.pdf?1774961113","publication_date":"2026-04-01","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/04/01/2026-06283.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2026-04-01T08:13:50Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":16205,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration","toc_doc":"Perpetual Biosciences, Inc.; Pigment Epithelium-Derived Factor Peptides and Use for Treating Retinal Degeneration","toc_subject":"Prospective Grant of an Exclusive Patent License","topics":[],"type":"Notice","volume":91}